Cargando…
The Chromatin Modifier MSK1/2 Suppresses Endocrine Cell Fates during Mouse Pancreatic Development
Type I diabetes is caused by loss of insulin-secreting beta cells. To identify novel, pharmacologically-targetable histone-modifying proteins that enhance beta cell production from pancreatic progenitors, we performed a screen for histone modifications induced by signal transduction pathways at key...
Autores principales: | Bhat, Neha, Park, Jeehye, Zoghbi, Huda Y., Arthur, J. Simon C., Zaret, Kenneth S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156359/ https://www.ncbi.nlm.nih.gov/pubmed/27973548 http://dx.doi.org/10.1371/journal.pone.0166703 |
Ejemplares similares
-
Emerging Roles of the Mitogen and Stress Activated Kinases MSK1 and MSK2
por: Reyskens, Kathleen M. S. E., et al.
Publicado: (2016) -
miR-93 regulates Msk2-mediated chromatin remodelling in diabetic nephropathy
por: Badal, Shawn S., et al.
Publicado: (2016) -
The kinase MSK1 is required for induction of c-fos by lysophosphatidic acid in mouse embryonic stem cells
por: Schuck, Sebastian, et al.
Publicado: (2003) -
Chromatin‐modifying drugs and metabolites in cell fate control
por: Yao, Ziyue, et al.
Publicado: (2020) -
Editorial Seminars in MSK Radiology
por: Simoni, Paolo, et al.
Publicado: (2017)